Neninger Vinageras E.
212
Coauthors
20
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2001 | 1 |
2003 | 2 |
2005 | 1 |
2007 | 2 |
2008 | 1 |
2009 | 2 |
2011 | 1 |
2013 | 1 |
2015 | 1 |
2016 | 3 |
2017 | 1 |
2018 | 2 |
2020 | 1 |
2021 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Cáncer | 25 |
Inmunología | 9 |
Farmacología | 3 |
Medicina interna | 2 |
Medicamento | 2 |
Biología | 1 |
Ensayo clínico | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Enfermedades | 19 |
Farmacología y terapéutica | 14 |
Medicina y salud | 4 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 20 |
Google Scholar | 1 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
Tania Crombet | 17 |
Lage Davila A. | 12 |
Carmen Elena Viada | 11 |
García Verdecia B. | 9 |
Mazorra Z. | 7 |
González G. | 6 |
Rodríguez P.C. | 5 |
Luaces P.L.o. | 5 |
Catala M. | 4 |
Popa X. | 4 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
ReviewAbstract: Epidermal growth factor receptor (EGFR) is overexpressed in many epithelial tumors and its role in tPalabras claves:cancer vaccine, clinical trials, Epidermal growth factor, Epidermal growth factor receptor, lung cancer, Non-small-cell lung cancerAutores:García Verdecia B., Lage Davila A., Neninger Vinageras E., Rodríguez P.C., Tania CrombetFuentes:scopusTherapeutic vaccination with Epidermal Growth Factor (EGF) in advanced lung cancer: Analysis of pooled data from three clinical trials
ArticleAbstract: We have undertaken the analysis of pooled data from three pilot clinical trials of vaccination withPalabras claves:cancer vaccine, Epidermal growth factor, Non-small cell lung cancerAutores:Carmen Elena Viada, González G., Lage Davila A., Neninger Vinageras E., Tania CrombetFuentes:scopusCIMAvax-EGF: Toward long-term survival of advanced NSCLC
ReviewAbstract: Lung cancer remains one of the leading causes of cancer-related deaths. Non–small cell lung cancer (Palabras claves:cancer vaccine, CIMAvax-EGF, Clinical trial, EGF, Epidermal growth factor receptor, immunotherapy, non–small cell lung cancerAutores:Camilo Rodríguez, Carmen Elena Viada, Lage Davila A., Mazorra Z., Neninger Vinageras E., Saavedra Hernández D., Tania CrombetFuentes:scopusCIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer
ArticleAbstract: The results allowing the Cuban Regulatory Agency (CECMED) to grant the Sanitary Registration to thePalabras claves:cancer vaccine, CIMAvax-EGF, Fast-Track registration, NSCLC, Phase II-III clinical trialAutores:Arteaga N., Cuevas A., García Verdecia B., González G., Lage Davila A., Neninger Vinageras E., Rodríguez G., Tania Crombet, Viña L.Fuentes:scopusBiomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
ArticleAbstract: Purpose: There are well-known alterations occurring within the immune system with aging. CollectivelPalabras claves:cancer vaccine, Immunosenescence, Immunosenescence markers, Non-small cell lung cancerAutores:Fuentes K.P., García Verdecia B., González A., Lage Davila A., Luaces P.L.o., Mazorra Z., Neninger Vinageras E., Popa X., Saavedra Hernández D., Tania CrombetFuentes:scopus